-
$6 million for dementia research
https://braincanada.ca/about/news-updates/6-million-for-dementia-researchBrain Canada Foundation in partnership with the Alzheimer Society of Canada, Canadian Institutes of Health Research – Institute of Aging, and Research Manitoba are investing $5,989,000 in 44 dementia researchers as part of Alzheimer Society of Canada’s annual research competition. The Alzheimer...
-
$6M grant for new Open Science patient registry
https://braincanada.ca/about/news-updates/6m-grant-for-new-open-science-patient-registryDr. Guy Rouleau, The Neuro’s Director and principal investigator of the Neuro’s Virtual Integrated Patient Platform (NeuroVIPs). Goal is to accelerate research and let patients know how their data is helping find treatments. A $6M grant from Brain Canada will fund the creation of a new Open...
-
[99m]Technetium-based radioligands for improving access to state-of-the-art molecular imaging of neurodegeneration
https://braincanada.ca/funded-grants/99m-technetium-based-radioligands-for-improving-access-to-state-of-the-art-molecular-imaging-of-neurodegenerationMedical imaging has changed how we study and treat brain degeneration. Project Overview Medical imaging has changed how we study and treat brain degeneration. The best tool for imaging subtle changes to brain proteins is positron emission tomography (or PET). But that has limited availability. An...
-
A brain-specific approach to RNA therapeutics: developing a novel protein delivery strategy for the central nervous system
https://braincanada.ca/funded-grants/a-brain-specific-approach-to-rna-therapeutics-developing-a-novel-protein-delivery-strategy-for-the-central-nervous-systemChallenge: Delivery of therapeutic proteins to the brain has been a longstanding barrier to CNS drug development. Project Overview Challenge: Delivery of therapeutic proteins to the brain has been a longstanding barrier to CNS drug development. Protein replacement or supplementation strategies hold...
-
A Catalyst for Global Connections: Science without Barriers or Borders
https://braincanada.ca/about/news-updates/a-catalyst-for-global-connections-science-without-barriers-or-bordersTaufik Valiante, Ph. D. Brain Canada’s vision of science without barriers or borders is promoting global thought and connections. Innovation does not hold a passport or recognize frontiers. Science knows no nation. The understanding of the brain, in health and in illness, requires knowledge,...
-
A combined in-vivo ex-vivo approach to investigate imaging biomarkers in ALS diagnosis and aetiology
https://braincanada.ca/funded-grants/a-combined-in-vivo-ex-vivo-approach-to-investigate-imaging-biomarkers-in-als-diagnosis-and-aetiologyAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor function and ultimately death. Project Overview Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor...
-
A critical examination of family caregivers’ views on and experiences with medical assistance in dying
https://braincanada.ca/funded-grants/a-critical-examination-of-family-caregivers-views-on-and-experiences-with-medical-assistance-in-dyingIndividuals with an incurable condition marked by decline and intolerable suffering and where death is reasonably foreseeable, as with dementia, now have access to medical assistance in dying (MAID). Project Overview Individuals with an incurable condition marked by decline and intolerable...
-
A Drug Screening Assay to Reduce LINGO-1 Amounts in Neurons
https://braincanada.ca/funded-grants/a-drug-screening-assay-to-reduce-lingo-1-amounts-in-neuronsThe LINGO-1 protein is strongly associated with Alzheimer’s disease and is a novel drug target. Project Overview The LINGO-1 protein is strongly associated with Alzheimer’s disease and is a novel drug target. LINGO-1 is a transmembrane protein that negatively regulates neuronal survival and...
-
A Drug Screening Platform to Increase Protein Expression Levels for Treatment of Neurological Disorders
https://braincanada.ca/funded-grants/a-drug-screening-platform-to-increase-protein-expression-levels-for-treatment-of-neurological-disordersNeurological and psychiatric diseases and disorders affect more than half the population. Project Overview Neurological and psychiatric diseases and disorders affect more than half the population. These disorders of the nervous system can span a range of illnesses, including generalized anxiety...
-
A future, Future Leader explores what it means to be a neuroscientist, on world stage
https://braincanada.ca/about/news-updates/brainbeesCanadian Brain Bee Champion Emma Rees travels to Spain and uncovers the key ingredient to a meaningful career in science - connection Canadian Brain Bee Champion Emma Rees travels to Spain and uncovers the key ingredient to a meaningful career in science - connection By Emma Rees There is a...
Skip to main content
